Topical bioequivalence: Experimental and regulatory considerations following formulation complexity.

Miranda, Margarida; Veloso, Cláudia; Brown, Marc; C Pais, Alberto A C; Cardoso, Catarina; Vitorino, Carla

Miranda, Margarida; Veloso, Cláudia; Brown, Marc; C Pais, Alberto A C; Cardoso, Catarina; Vitorino, Carla.

Afiliación

Miranda M; Faculty of Pharmacy, University of Coimbra, Portugal; Coimbra Chemistry Center, Department of Chemistry, University of Coimbra, Portugal.
Veloso C; Faculty of Pharmacy, University of Coimbra, Portugal; Coimbra Chemistry Center, Department of Chemistry, University of Coimbra, Portugal.
Brown M; MedPharm Ltd, Surrey Research Centre, Guildford, Surrey, UK.
C Pais AAC; Coimbra Chemistry Center, Department of Chemistry, University of Coimbra, Portugal.
Cardoso C; Laboratórios Basi, Mortágua, Portugal.
Vitorino C; Faculty of Pharmacy, University of Coimbra, Portugal; Coimbra Chemistry Center, Department of Chemistry, University of Coimbra, Portugal; Centre for Neurosciences and Cell Biology (CNC), University of Coimbra, Portugal. Electronic address: csvitorino@ff.uc.pt.

Int J Pharm ; 620: 121705, 2022 May 25.

Article en En | MEDLINE | ID: mdl-35358644

Asunto(s)

Diclofenaco; Dimetindeno; Diclofenaco/química; Medicamentos Genéricos; Humanos; Técnicas In Vitro; Equivalencia Terapéutica

Palabras clave

Bioequivalence; Diclofenac; Dimetindene; EMA; FDA; Topical generic products

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_medicamentos_vacinas_tecnologias Asunto principal: Diclofenaco / Dimetindeno Tipo de estudio: Guideline / Qualitative_research Límite: Humans Idioma: En Revista: Int J Pharm Año: 2022 Tipo del documento: Article País de afiliación: Portugal

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google